These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26293838)

  • 1. Genetic alterations in uterine fibroids - a new direction for pharmacological intervention?
    Markowski DN; Holzmann C; Bullerdiek J
    Expert Opin Ther Targets; 2015; 19(11):1485-94. PubMed ID: 26293838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine fibroids: do we deal with more than one disease?
    Markowski DN; Helmke BM; Bartnitzke S; Löning T; Bullerdiek J
    Int J Gynecol Pathol; 2014 Nov; 33(6):568-72. PubMed ID: 25272295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
    Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
    Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations.
    Nadine Markowski D; Tadayyon M; Bartnitzke S; Belge G; Maria Helmke B; Bullerdiek J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):317-23. PubMed ID: 24446130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
    Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
    Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of multiple uterine leiomyomas, parametrial leiomyoma and disseminated peritoneal leiomyomatosis.
    Mark J; Havel G; Dahlenfors R; Wedell B
    Anticancer Res; 1991; 11(1):33-9. PubMed ID: 2018368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytogenetic subtyping of 139 uterine leiomyoma].
    Stern C; Deichert U; Thode B; Bartnitzke S; Bullerdiek J
    Geburtshilfe Frauenheilkd; 1992 Dec; 52(12):767-72. PubMed ID: 1490556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
    Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
    BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Uterine Fibroid Etiology.
    McWilliams MM; Chennathukuzhi VM
    Semin Reprod Med; 2017 Mar; 35(2):181-189. PubMed ID: 28278535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics of uterine leiomyomata].
    Pedeutour F; Ligon AH; Morton CC
    Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
    Bloch J; Holzmann C; Koczan D; Helmke BM; Bullerdiek J
    Oncotarget; 2017 May; 8(21):34762-34772. PubMed ID: 28410233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine leiomyomas: cytogenetic and histologic profile.
    Meloni AM; Surti U; Contento AM; Davare J; Sandberg AA
    Obstet Gynecol; 1992 Aug; 80(2):209-17. PubMed ID: 1635734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of chromosomal abnormalities of chromosome 12 in uterine leiomyoma using fluorescence in situ hybridization.
    Hayashi S; Miharu N; Okamoto E; Samura O; Hara T; Ohama K
    Jpn J Hum Genet; 1996 Mar; 41(1):193-202. PubMed ID: 8914635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple uterine leiomyomas: cytogenetic analysis.
    Mantovani MS; Neto JB; Philbert PM; Casartelli C
    Gynecol Oncol; 1999 Jan; 72(1):71-5. PubMed ID: 9889033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.